eXoZymes Insider Trades
NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $6.41K
- Sales
- 3 · $34.85K
- Shares bought / sold
- 855 / 5.23K
- Net activity
- Net selling $28,446
eXoZymes insider activity
Over the last 12 months, eXoZymes insiders reported 17 transactions on SEC Form 4: 5 open-market purchases and 3 sales. Insiders bought $6,405 and sold $34,851 worth of stock, for net insider selling of $28,446. The largest seller was Perriman Damien Alan, with $19,427 in reported sales.
The most recent filing shows Perriman Damien Alan (Chief Commercial Officer) selling 3,729 shares at $5.21 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EXOZ's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
EXOZ insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 12, 2026 | Perriman Damien AlanChief Commercial Officer | Sale | 3,729 | $19.43K | Form 4 |
| Oct 9, 2026 | Perriman Damien AlanChief Commercial Officer | Option exercise | 3,922 | — | Form 4 |
| Aug 26, 2026 | Heltzen MichaelChief Executive Officer | Buy | 250 | $1.90K | Form 4 |
| Aug 26, 2026 | Heltzen MichaelChief Executive Officer | Buy | 251 | $1.84K | Form 4 |
| Aug 26, 2026 | Heltzen MichaelChief Executive Officer | Buy | 4 | $30.32 | Form 4 |
| Aug 25, 2026 | Heltzen MichaelChief Executive Officer | Buy | 100 | $750 | Form 4 |
| Aug 25, 2026 | Heltzen MichaelChief Executive Officer | Buy | 250 | $1.88K | Form 4 |
| Aug 19, 2026 | Korman Tyler PazChief Scientific Officer | Option exercise | 32,964 | — | Form 4 |
| Aug 19, 2026 | Perriman Damien AlanChief Commercial Officer | Option exercise | 19,612 | — | Form 4 |
| Aug 19, 2026 | Heltzen MichaelChief Executive Officer | Award | 8,841 | $56.58K | Form 4 |
| Apr 9, 2026 | Korman Tyler PazChief Scientific Officer | Sale | 750 | $7.89K | Form 4 |
| Apr 8, 2026 | Korman Tyler PazChief Scientific Officer | Sale | 750 | $7.53K | Form 4 |
| Apr 1, 2026 | Korman Tyler PazChief Scientific Officer | Award | 5,332 | $45.00K | Form 4 |
| Apr 1, 2026 | Nawaz FouadVice President- Finance | Award | 5,999 | $50.63K | Form 4 |
| Apr 1, 2026 | Opgenorth Paul HideoVice President, Development | Award | 3,999 | $33.75K | Form 4 |
| Apr 1, 2026 | Perriman Damien AlanChief Commercial Officer | Award | 8,887 | $75.01K | Form 4 |
| Apr 1, 2026 | Perriman Damien AlanChief Commercial Officer | Award | 62,759 | — | Form 4 |
| Jul 2, 2025 | Heltzen MichaelChief Executive Officer | Buy | 1,040 | $10.63K | Form 4 |
| Jun 16, 2025 | Korman Tyler PazVice President, Research | Award | 2,990 | $37.49K | Form 4 |
| Jun 13, 2025 | Nawaz FouadVice President, Finance | Award | 3,489 | $43.75K | Form 4 |
| Jun 13, 2025 | Opgenorth Paul HideoVice President, Development | Award | 2,990 | $37.49K | Form 4 |
| Jan 17, 2025 | Heltzen MichaelChief Executive Officer | Buy | 1,767 | $19.05K | Form 4 |
| Jan 16, 2025 | Heltzen MichaelChief Executive Officer | Buy | 121 | $1.30K | Form 4 |
| Nov 15, 2024 | Heltzen MichaelChief Executive Officer | Buy | 1,984 | $22.02K | Form 4 |
| Nov 8, 2024 | MDB Capital Holdings, LLC10% Owner | Conversion | 122,657 | $785.00K | Form 4 |
| Nov 8, 2024 | Opgenorth Paul HideoVice President, Development | Conversion | 2,344 | $15.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4